{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T20:34:53Z","timestamp":1764102893839,"version":"3.37.3"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T00:00:00Z","timestamp":1506470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T00:00:00Z","timestamp":1506470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1111\/bjd.15500","type":"journal-article","created":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T13:58:32Z","timestamp":1500386312000},"page":"e150-e151","source":"Crossref","is-referenced-by-count":17,"title":["Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?"],"prefix":"10.1093","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2439-920X","authenticated-orcid":false,"given":"P.","family":"Mendes-Bastos","sequence":"first","affiliation":[{"name":"Hospital CUF Descobertas - Dermatology Centre; Lisboa Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Macedo","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department; Instituto Nacional de Saude Dr Ricardo Jorge - Laborat\u00f3rio Nacional de Refer\u00eancia de Micobact\u00e9rias; Lisboa Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Duarte","sequence":"additional","affiliation":[{"name":"Institute of Public Health; Universidade do Porto, EpiUnit; Porto Portugal"},{"name":"Faculdade de Medicina, Department of Clinical Epidemiology, Predictive Medicine and Public Health; Universidade do Porto; Porto Portugal"},{"name":"Centro Hospitalar de Vila Nova de Gaia\/Espinho, Pulmonology Department; Vila Nova de Gaia Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,9,27]]},"reference":[{"key":"10.1111\/bjd.15500-BIB0001|bjd15500-cit-0001","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1365-2133.2006.07155.x","article-title":"Clindamycin and rifampicin combination therapy for hidradenitis suppurativa","volume":"154","author":"Mendonca","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15500-BIB0002|bjd15500-cit-0002","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","article-title":"Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients","volume":"219","author":"Gener","year":"2009","journal-title":"Dermatology"},{"key":"10.1111\/bjd.15500-BIB0003|bjd15500-cit-0003","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000228337","article-title":"The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa","volume":"219","author":"Zee","year":"2009","journal-title":"Dermatology"},{"key":"10.1111\/bjd.15500-BIB0004|bjd15500-cit-0004","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jdv.12127","article-title":"Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients","volume":"28","author":"Bettoli","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.15500-BIB0005|bjd15500-cit-0005","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/ced.12933","article-title":"Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up","volume":"41","author":"Dessinioti","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.15500-BIB0006|bjd15500-cit-0006","doi-asserted-by":"crossref","DOI":"10.5070\/D3226031313","article-title":"Why rifampin (rifampicin) is a key component in the antibiotic treatment of hidradenitis suppurativa: a review of rifampin's effects on bacteria, bacterial biofilms, and the human immune system","volume":"22","author":"Scheinfeld","year":"2016","journal-title":"Dermatol Online J"},{"key":"10.1111\/bjd.15500-BIB0007|bjd15500-cit-0007","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1128\/AAC.47.10.3037-3039.2003","article-title":"Treatment of chronic infections with rifamycins: is resistance likely to follow?","volume":"47","author":"Chaisson","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/bjd.15500-BIB0008|bjd15500-cit-0008","doi-asserted-by":"crossref","first-page":"e02220","DOI":"10.1128\/AAC.02220-16","article-title":"Acquisition of rifampin resistance in pulmonary tuberculosis","volume":"61","author":"Kayigire","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/bjd.15500-BIB0009|bjd15500-cit-0009","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000321716","article-title":"Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa","volume":"222","author":"Join-Lambert","year":"2011","journal-title":"Dermatology"},{"key":"10.1111\/bjd.15500-BIB0010|bjd15500-cit-0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00005792-199911000-00001","article-title":"Hypersensitivity reactions to rifampin. Pathogenic mechanisms, clinical manifestations, management strategies and review of the anaphylactic-like reactions","volume":"78","author":"Martinez","year":"1999","journal-title":"Medicine (Baltimore)"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.15500","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.15500\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:26:31Z","timestamp":1676384791000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/177\/4\/e150\/6674125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,27]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.15500","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"type":"print","value":"0007-0963"}],"subject":[],"published":{"date-parts":[[2017,9,27]]}}}